vs
Side-by-side financial comparison of EMERSON RADIO CORP (MSN) and Q32 Bio Inc. (QTTB). Click either name above to swap in a different company.
Q32 Bio Inc. is the larger business by last-quarter revenue ($1.9M vs $1.9M, roughly 1.0× EMERSON RADIO CORP). Q32 Bio Inc. runs the higher net margin — 2991.2% vs -36.7%, a 3027.9% gap on every dollar of revenue.
Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.
MSN vs QTTB — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9M | $1.9M |
| Net Profit | $-694.0K | $57.7M |
| Gross Margin | 10.9% | — |
| Operating Margin | -43.7% | — |
| Net Margin | -36.7% | 2991.2% |
| Revenue YoY | -52.8% | — |
| Net Profit YoY | -31.7% | 506.9% |
| EPS (diluted) | $-0.03 | $4.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9M | $1.9M | ||
| Q3 25 | $1.2M | $-220.0K | ||
| Q2 25 | $1.7M | $-284.0K | ||
| Q1 25 | $1.8M | $-371.0K | ||
| Q4 24 | $4.0M | $0 | ||
| Q3 24 | $2.7M | $0 | ||
| Q2 24 | $2.2M | $0 | ||
| Q1 24 | $2.2M | $0 |
| Q4 25 | $-694.0K | $57.7M | ||
| Q3 25 | $-1.0M | $-7.4M | ||
| Q2 25 | $-1.1M | $-9.5M | ||
| Q1 25 | $-2.4M | $-11.0M | ||
| Q4 24 | $-527.0K | $-14.2M | ||
| Q3 24 | $-881.0K | $-17.6M | ||
| Q2 24 | $-962.0K | $-17.0M | ||
| Q1 24 | $-883.0K | $1.0M |
| Q4 25 | 10.9% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | -3.0% | — | ||
| Q4 24 | 12.3% | — | ||
| Q3 24 | 9.9% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 15.9% | — |
| Q4 25 | -43.7% | — | ||
| Q3 25 | -98.4% | 3444.1% | ||
| Q2 25 | -78.1% | 3229.2% | ||
| Q1 25 | -137.8% | 3296.0% | ||
| Q4 24 | -18.3% | — | ||
| Q3 24 | -40.8% | — | ||
| Q2 24 | -55.6% | — | ||
| Q1 24 | -52.2% | — |
| Q4 25 | -36.7% | 2991.2% | ||
| Q3 25 | -85.8% | 3358.6% | ||
| Q2 25 | -68.1% | 3341.2% | ||
| Q1 25 | -127.9% | 2973.3% | ||
| Q4 24 | -13.2% | — | ||
| Q3 24 | -32.2% | — | ||
| Q2 24 | -43.8% | — | ||
| Q1 24 | -40.1% | — |
| Q4 25 | $-0.03 | $4.70 | ||
| Q3 25 | $-0.05 | $-0.60 | ||
| Q2 25 | $-0.05 | $-0.78 | ||
| Q1 25 | $-0.10 | $-0.90 | ||
| Q4 24 | $-0.03 | $2.63 | ||
| Q3 24 | $-0.04 | $-1.46 | ||
| Q2 24 | $-0.05 | $-1.42 | ||
| Q1 24 | $-0.04 | $-6.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.3M | $48.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.6M | $42.0M |
| Total Assets | $20.1M | $61.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.3M | $48.3M | ||
| Q3 25 | $13.5M | $49.0M | ||
| Q2 25 | $15.5M | $54.8M | ||
| Q1 25 | $16.1M | $65.5M | ||
| Q4 24 | $16.4M | $78.0M | ||
| Q3 24 | $16.7M | $89.1M | ||
| Q2 24 | $18.9M | $97.7M | ||
| Q1 24 | $19.9M | $115.5M |
| Q4 25 | $18.6M | $42.0M | ||
| Q3 25 | $19.3M | $-18.4M | ||
| Q2 25 | $20.4M | $-12.2M | ||
| Q1 25 | $21.5M | $-4.0M | ||
| Q4 24 | $23.9M | $5.7M | ||
| Q3 24 | $24.4M | $18.3M | ||
| Q2 24 | $25.3M | $33.5M | ||
| Q1 24 | $26.2M | $48.8M |
| Q4 25 | $20.1M | $61.8M | ||
| Q3 25 | $20.7M | $57.8M | ||
| Q2 25 | $23.3M | $66.1M | ||
| Q1 25 | $23.5M | $79.1M | ||
| Q4 24 | $26.4M | $92.3M | ||
| Q3 24 | $26.6M | $104.5M | ||
| Q2 24 | $28.5M | $124.2M | ||
| Q1 24 | $29.1M | $152.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-228.0K | $-6.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -0.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-228.0K | $-6.2M | ||
| Q3 25 | $-2.0M | $-4.2M | ||
| Q2 25 | $-514.0K | $-10.7M | ||
| Q1 25 | $-391.0K | $-12.5M | ||
| Q4 24 | $-293.0K | $-11.4M | ||
| Q3 24 | $-2.1M | $-19.5M | ||
| Q2 24 | $-840.0K | $-22.2M | ||
| Q1 24 | $-2.2M | $-14.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-301.0K | $-11.4M | ||
| Q3 24 | $-2.1M | $-19.6M | ||
| Q2 24 | $-1.0M | $-22.2M | ||
| Q1 24 | $-2.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -7.5% | — | ||
| Q3 24 | -77.8% | — | ||
| Q2 24 | -46.4% | — | ||
| Q1 24 | -102.3% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 8.2% | — | ||
| Q1 24 | 0.5% | — |
| Q4 25 | — | -0.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSN
| Products | $1.8M | 95% |
| Other | $87.0K | 5% |
QTTB
Segment breakdown not available.
